Emerging therapies for antibody-mediated rejection in kidney transplantation

Authors

Farah Abuazzam, Washington University School of Medicine in St. Louis
Casey Dubrawka, Barnes-Jewish Hospital
Tarek Abdulhadi, Washington University School of Medicine in St. Louis
Gwendolyn Amurao, Washington University School of Medicine in St. Louis
Louai Alrata, Washington University School of Medicine in St. Louis
Dema Yaseen Alsabbagh, Washington University School of Medicine in St. Louis
Omar Alomar, Washington University School of Medicine in St. Louis
Tarek Alhamad, Washington University School of Medicine in St. Louis

Journal

Journal of Clinical Medicine

Publication Date

7-26-2023

Volume

12

Issue

15

First Page

4916

Document Type

Open Access Publication

DOI

10.3390/jcm12154916

Rights and Permissions

Abuazzam F, Dubrawka C, Abdulhadi T, Amurao G, Alrata L, Yaseen Alsabbagh D, Alomar O, Alhamad T. Emerging Therapies for Antibody-Mediated Rejection in Kidney Transplantation. J Clin Med. 2023 Jul 26;12(15):4916. doi: 10.3390/jcm12154916 Copyright: © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Recommended Citation

Abuazzam, Farah; Dubrawka, Casey; Abdulhadi, Tarek; Amurao, Gwendolyn; Alrata, Louai; Yaseen Alsabbagh, Dema; Alomar, Omar; and Alhamad, Tarek, "Emerging therapies for antibody-mediated rejection in kidney transplantation." Journal of Clinical Medicine. 12, 15. 4916 (2023).
https://digitalcommons.wustl.edu/oa_4/4245

Department

ICTS (Institute of Clinical and Translational Sciences)